Influence of Infusion Duration and Tubing Length on Insulin Lispro Stability in Subcutaneous Insulin Pump Delivery Systems

BACKGROUND: Subvisible particulates in insulin formulations pose risks because of their potential to cause pump occlusion and immune responses in patients during subcutaneous delivery through insulin pump systems. The impact of the length of the infusion set tube and the duration of infusion on particulates has not been fully characterized. Using insulin lispro as a model product, this in vitro study evaluated physical and chemical characterization methods for detecting subvisible particulates. METHOD: Insulin lispro was infused continuously at 0.2 U/h for 3 and 8 days using 2 pump-infusion set systems with tubing lengths ranging from 18 to 43 inches. Particulate characterization using flow imaging, chemical identification using morphologically directed Raman spectroscopy, and monomer and excipient characterization using size exclusion chromatography and gas chromatography-mass spectrometry were performed. RESULTS: < .05) than the compendial light obscuration method. Morphologically directed Raman spectroscopy identified silicone oil and polyethylene as primary constituents of particulates above 10 µm, indicating leaching of silicone oil from syringes and polyethylene shedding from infusion set tubing walls. CONCLUSIONS: Flow imaging proved more sensitive than light obscuration for this in vitro analysis. Polyethylene shed from infusion tubing was identified as a source of particulate matter. These findings suggest that sensitive analytical methods may offer utility in characterizing infusion set systems.

Authors

Institutions

Publication Details

Journal
Journal of Diabetes Science and Technology
Published
2026-11-20
DOI
https://doi.org/10.1177/19322968261501980
Primary Topic
Intravenous Infusion Technology and Safety
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Influence of Infusion Duration and Tubing Length on Insulin Lispro Stability in Subcutaneous Insulin Pump Delivery Systems

Martha A. Essandoh, Jackie L. Cullinan, Maxwell Korang‐Yeboah, Suvajyoti Guha et al.
Journal of Diabetes Science and Technology
Intravenous Infusion Technology and Safety
article

Influence of Infusion Duration and Tubing Length on Insulin Lispro Stability in Subcutaneous Insulin Pump Delivery Systems

Martha A. Essandoh, Jackie L. Cullinan, Maxwell Korang‐Yeboah, Suvajyoti Guha, Diaá M. Shakleya, Ashwinkumar A. Bhirde, Ali Bozorgnezhad, Isabella F de Luna
article en

Abstract

BACKGROUND: Subvisible particulates in insulin formulations pose risks because of their potential to cause pump occlusion and immune responses in patients during subcutaneous delivery through insulin pump systems. The impact of the length of the infusion set tube and the duration of infusion on particulates has not been fully characterized. Using insulin lispro as a model product, this in vitro study evaluated physical and chemical characterization methods for detecting subvisible particulates. METHOD: Insulin lispro was infused continuously at 0.2 U/h for 3 and 8 days using 2 pump-infusion set systems with tubing lengths ranging from 18 to 43 inches. Particulate characterization using flow imaging, chemical identification using morphologically directed Raman spectroscopy, and monomer and excipient characterization using size exclusion chromatography and gas chromatography-mass spectrometry were performed. RESULTS: < .05) than the compendial light obscuration method. Morphologically directed Raman spectroscopy identified silicone oil and polyethylene as primary constituents of particulates above 10 µm, indicating leaching of silicone oil from syringes and polyethylene shedding from infusion set tubing walls. CONCLUSIONS: Flow imaging proved more sensitive than light obscuration for this in vitro analysis. Polyethylene shed from infusion tubing was identified as a source of particulate matter. These findings suggest that sensitive analytical methods may offer utility in characterizing infusion set systems.

Journal of Diabetes Science and Technology
United States Food and Drug Administration (US), Center for Drug Evaluation and Research (US), Center for Devices and Radiological Health (US)
Intravenous Infusion Technology and Safety
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon